Ellington Management Group’s Haemonetics HAE Stock Holding History

Ellington Management Group’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,300	Closed	-$388K	–	630
2018 Q1	$388K	Buy	5,300 +800	+18%	+$54.9K	0.03%	486
2017 Q4	$261K	Sell	4,500 -3,800	-46%	-$200K	0.04%	406
2017 Q3	$372K	Buy	+8,300	New	+$345K	0.06%	309
2013 Q4	–	Sell	-6,600	Closed	-$263K	–	645
2013 Q3	$263K	Sell	6,600 -5,500	-45%	-$231K	0.05%	563
2013 Q2	$500K	Buy	+12,100	New	+$490K	0.1%	308

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ellington Management Group's HAE Position: Q2 2018 in Review

Ellington Management Group sold out of Haemonetics (HAE) in Q2 2018, closing a stake of 5,300 shares — an estimated $388K sold.

Ellington Management Group first reported a position in HAE in Q2 2013 and held it in 5 quarters. The position peaked at $500K in Q2 2013. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

Ellington Management Group reported no remaining Haemonetics position as of Q2 2018 after selling out during the quarter.
Ellington Management Group sold 5,300 Haemonetics shares in Q2 2018, an estimated $388K.
Ellington Management Group first reported a position in Haemonetics in Q2 2013 and held it in 5 quarters.
Ellington Management Group's Haemonetics position peaked at $500K in Q2 2013.
293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.